Perforating dermatosis associated with multikinase inhibitors [Carta]: report of two cases, including one associated with lenvatinib (2018)
- Authors:
- USP affiliated authors: LINS, JADE CURY MARTINS ASFORA - FM ; SANCHES JUNIOR, JOSE ANTONIO - FM
- Unidade: FM
- DOI: 10.1111/ddg.13704
- Subjects: DERMATOPATIAS; INIBIDORES DE ENZIMAS
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal der deutschen dermatologischen gesellschaft
- ISSN: 1610-0379
- Volume/Número/Paginação/Ano: v. 16, n. 12, p. 1486-1489, 2018
- Este artigo NÃO possui versão em acesso aberto
-
Status: Nenhuma versão em acesso aberto identificada -
ABNT
SATO-SANO, Marcelo et al. Perforating dermatosis associated with multikinase inhibitors [Carta]: report of two cases, including one associated with lenvatinib. Journal der deutschen dermatologischen gesellschaft. Hoboken: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1111/ddg.13704. Acesso em: 11 mar. 2026. , 2018 -
APA
Sato-sano, M., Cury-martins, J., Sanches, J. A., Macarenco, R., Domingues, R. B., & Vasconcelos, R. (2018). Perforating dermatosis associated with multikinase inhibitors [Carta]: report of two cases, including one associated with lenvatinib. Journal der deutschen dermatologischen gesellschaft. Hoboken: Faculdade de Medicina, Universidade de São Paulo. doi:10.1111/ddg.13704 -
NLM
Sato-sano M, Cury-martins J, Sanches JA, Macarenco R, Domingues RB, Vasconcelos R. Perforating dermatosis associated with multikinase inhibitors [Carta]: report of two cases, including one associated with lenvatinib [Internet]. Journal der deutschen dermatologischen gesellschaft. 2018 ; 16( 12): 1486-1489.[citado 2026 mar. 11 ] Available from: https://doi.org/10.1111/ddg.13704 -
Vancouver
Sato-sano M, Cury-martins J, Sanches JA, Macarenco R, Domingues RB, Vasconcelos R. Perforating dermatosis associated with multikinase inhibitors [Carta]: report of two cases, including one associated with lenvatinib [Internet]. Journal der deutschen dermatologischen gesellschaft. 2018 ; 16( 12): 1486-1489.[citado 2026 mar. 11 ] Available from: https://doi.org/10.1111/ddg.13704 - Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel
- Acquired lipodystrophy associated with nivolumab in a patient with advanced renal cell carcinoma
- Acquired lipodystrophy associated with nivolumab in a patient with advanced renal cell carcinoma
- A unique case of a lymphoproliferative disorder affecting the skin and uterine cervix on a male transgender
- Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study
- Dermoscopy of primary cutaneous B- and T-cell lymphomas and pseudolymphomas presenting as solitary nodules and tumors: a case-control study with histopathologic correlation
- Case for diagnosis. Erythematous-violaceous reticulated plaques on the breasts [Editorial]
- Folliculotropic mycosis fungoides: clinical and epidemiological evaluation in a single center in Brazil
- Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
- Consensuses, guidelines and position papers [Editorial]: the role of the Brazilian Society of Dermatology in the contribution to the best practice of Dermatology
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
